The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant …
Source link
25
JAN
2020
JAN
2020
0
$22 Million Joint Venture To Purse Neurochemical Reset For Addiction
Posted by: